Center for Scientific Review; Notice of Closed Meetings, 5259-5260 [2012-2324]
Download as PDF
<![CDATA[
5259
Federal Register / Vol. 77, No. 22 / Thursday, February 2, 2012 / Notices
waiver demonstration projects in each
of Fiscal Years 2012, 2013 and 2014.
These demonstration waiver projects
involve the waiver of certain
requirements of title IV–E and IV–B.
These projects do not provide additional
funding to carry out new services; rather
they allow more flexible uses of Federal
funds in order to test new approaches to
service delivery or financing structures
in an effort to improve outcomes for
children and families involved in the
child welfare system. We encourage title
IV–E agencies wishing to apply for
approval of a waiver demonstration
project to submit a letter of intent
followed by a full proposal at a later
date. For title IV–E agencies that choose
to submit a letter of intent, the letter of
intent should indicate the title IV–E
agency’s intent to submit a proposal,
and briefly describe the demonstration
project, including the nature of the
intervention the agency wishes to
implement, the target population the
agency wishes to serve, the reasons for
selecting the proposed project and the
evaluation design that the agency is
considering. The full proposal must
describe the project in extensive detail
including the goals identified in statute
that the project is intended to
accomplish, the geographic areas in
which the proposed project will be
conducted, the service interventions to
be implemented, the impact
intervention is expected to have on
outcomes related to safety, permanency,
well-being, how service provision will
change for children and families under
the waiver demonstration, a statement
of program requirements for waivers
needed to conduct the project, an
estimate of the projected costs or
savings of the proposed project, a
description of the proposed evaluation
design and an accounting of any other
sources of funding that have been used
to provide the services that the agency
now proposes to address under a waiver
demonstration.
Respondents: States.
ANNUAL BURDEN ESTIMATES
Number of
respondents
Instrument
Number of
responses
per
respondent
10
10
1
1
srobinson on DSK4SPTVN1PROD with NOTICES
Letter of intent ..................................................................................................................
Full proposal ....................................................................................................................
Estimated Total Annual Burden
Hours: 450.
In compliance with the requirements
of Section 506(c)(2)(A) of the Paperwork
Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Planning, Research
and Evaluation, 370 L’Enfant
Promenade SW., Washington, DC 20447,
Attn: ACF Reports Clearance Officer.
Email address:
infocollection@acf.hhs.gov. All requests
should be identified by the title of the
information collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden
information to be collected; and (e)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
VerDate Mar<15>2010
17:04 Feb 01, 2012
Jkt 226001
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2012–2320 Filed 2–1–12; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cardiac Electrophysiology,
Arrhythmia and Sleep Apnea.
Date: February 15, 2012.
Time: 2 p.m. to 5 p.m.
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Average
burden
hours per
response
5
40
Total
burden
hours
50
400
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Olga A. Tjurmina, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4138,
MSC 7814, Bethesda, MD 20892, (301) 451–
1375, ot3d@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Special
Topics: Topics in Bacterial Pathogenesis.
Date: March 1–2, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, VA 22314.
Contact Person: Rolf Menzel, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3196,
MSC 7808, Bethesda, MD 20892, (301) 435–
0952, menzelro@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Non-HIV Diagnostics, Food Safety,
Sterilization/Disinfection and
Bioremediation.
Date: March 1–2, 2012.
Time: 8 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Regis Hotel, 923 16th and K
Streets NW., Washington, DC 20006.
Contact Person: Gagan Pandya, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, RM 3200, MSC 7808,
Bethesda, MD 20892, (301) 435–1167,
pandyaga@mai.nih.gov.
E:\FR\FM\02FEN1.SGM
02FEN1
srobinson on DSK4SPTVN1PROD with NOTICES
5260
Federal Register / Vol. 77, No. 22 / Thursday, February 2, 2012 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–OD11–
003: Specialized Centers of Research (SCOR)
on Sex Differences.
Date: March 1–2, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Robert Garofalo, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6156,
MSC 7892, Bethesda, MD 20892, (301) 435–
1043, garofalors@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Drug Discovery for Aging,
Neuropsychiatric and Neurologic Disorders.
Date: March 1, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Delfina, 530 Pico
Boulevard, Santa Monica, CA 90405.
Contact Person: Dan D Gerendasy, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3218,
MSC 7843, Bethesda, MD 20892, (301) 408–
9164, gerendad@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Biophysical, Physiological,
Pharmacological and Bioengineering
Neuroscience.
Date: March 1–2, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott &
Conference Center, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: J Scott Osborne, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4114,
MSC 7816, Bethesda, MD 20892, (301) 435–
1782, osbornes@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Virology.
Date: March 1–2, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Fouad A El-Zaatari, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206,
MSC 7808, Bethesda, MD 20814–9692, (301)
435–1149, elzaataf@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Sensory Technologies.
Date: March 1–2, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Fairmont San Francisco, 950 Mason
Street, San Francisco, CA 94108.
VerDate Mar<15>2010
17:04 Feb 01, 2012
Jkt 226001
Contact Person: Paek-Gyu Lee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4201,
MSC 7812, Bethesda, MD 20892, (301) 613–
2064, leepg@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Non-HIV Anti-Infective
Therapeutics.
Date: March 1–2, 2012.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marina del Rey Hotel, 13534 Bali
Way, Waterfront Conference Room, Marina
del Rey, CA 90292.
Contact Person: Kenneth M Izumi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Rm 3204, MSC
7808, Bethesda, MD 20892, (301) 496–6980,
izumikm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Microbial Pathogens.
Date: March 1–2, 2012.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Liangbiao Zheng, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3202,
MSC 7808, Bethesda, MD 20892, (301) 996–
5819, zhengli@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–11–
304: Development of Appropriate Pediatric
Formulations and Drug Delivery Systems.
Date: March 2, 2012.
Time: 8 a.m. to 10 a.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Delfina, 530 Pico
Boulevard, Santa Monica, CA 90405.
Contact Person: Dan D Gerendasy, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3218,
MSC 7843, Bethesda, MD 20892, (301) 408–
9164, gerendad@csr.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Biostatistical Methods and Research Design
Study Section.
Date: March 2, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Kabuki, 1625 Post Street, San
Francisco, CA 94115.
Contact Person: Tomas Drgon, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3152,
MSC 7770, Bethesda, MD 20892, (301) 435–
1017, tdrgon@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–09–
259 and PAR–09–260: Optimization of Small
Molecule Probes for the Nervous System.
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Date: March 2, 2012.
Time: 10 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Delfina, 530 Pico
Boulevard, Santa Monica, CA 90405.
Contact Person: Dan D Gerendasy, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3218,
MSC 7843, Bethesda, MD 20892, (301) 408–
9164, gerendad@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 27, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–2324 Filed 2–1–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Immunobiology.
Date: February 23–24, 2012.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Stephen M. Nigida, Ph.D.,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4212,
MSC 7812, Bethesda, MD 20892, (301) 435–
1222, nigidas@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Overflow:
Cancer Therapeutics.
Date: February 27, 2012.
Time: 8 a.m. to 6 p.m.
E:\FR\FM\02FEN1.SGM
02FEN1
]]>Agencies
[Federal Register Volume 77, Number 22 (Thursday, February 2, 2012)]
[Notices]
[Pages 5259-5260]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-2324]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Cardiac Electrophysiology, Arrhythmia and
Sleep Apnea.
Date: February 15, 2012.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Olga A. Tjurmina, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4138, MSC 7814, Bethesda, MD
20892, (301) 451-1375, ot3d@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Special Topics: Topics in Bacterial Pathogenesis.
Date: March 1-2, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria,
VA 22314.
Contact Person: Rolf Menzel, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3196, MSC 7808, Bethesda, MD 20892, (301) 435-
0952, menzelro@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Non-HIV Diagnostics, Food Safety,
Sterilization/Disinfection and Bioremediation.
Date: March 1-2, 2012.
Time: 8 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: St. Regis Hotel, 923 16th and K Streets NW., Washington,
DC 20006.
Contact Person: Gagan Pandya, Ph.D., Scientific Review Officer,
National Institutes of Health, Center for Scientific Review, 6701
Rockledge Drive, RM 3200, MSC 7808, Bethesda, MD 20892, (301) 435-
1167, pandyaga@mai.nih.gov.
[[Page 5260]]
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-OD11-003: Specialized Centers of Research (SCOR) on Sex
Differences.
Date: March 1-2, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select),
8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Robert Garofalo, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6156, MSC 7892, Bethesda, MD
20892, (301) 435-1043, garofalors@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Drug Discovery for Aging, Neuropsychiatric
and Neurologic Disorders.
Date: March 1, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Delfina, 530 Pico Boulevard, Santa Monica, CA
90405.
Contact Person: Dan D Gerendasy, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3218, MSC 7843, Bethesda, MD
20892, (301) 408-9164, gerendad@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Biophysical, Physiological, Pharmacological and
Bioengineering Neuroscience.
Date: March 1-2, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott & Conference Center, 5701
Marinelli Road, North Bethesda, MD 20852.
Contact Person: J Scott Osborne, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4114, MSC 7816, Bethesda, MD
20892, (301) 435-1782, osbornes@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Virology.
Date: March 1-2, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Fouad A El-Zaatari, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206, MSC 7808, Bethesda, MD
20814-9692, (301) 435-1149, elzaataf@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Sensory Technologies.
Date: March 1-2, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Fairmont San Francisco, 950 Mason Street, San Francisco,
CA 94108.
Contact Person: Paek-Gyu Lee, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4201, MSC 7812, Bethesda, MD 20892, (301) 613-
2064, leepg@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Non-HIV Anti-Infective Therapeutics.
Date: March 1-2, 2012.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Marina del Rey Hotel, 13534 Bali Way, Waterfront
Conference Room, Marina del Rey, CA 90292.
Contact Person: Kenneth M Izumi, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Rm 3204, MSC 7808, Bethesda, MD 20892,
(301) 496-6980, izumikm@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Topics in Microbial Pathogens.
Date: March 1-2, 2012.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Liangbiao Zheng, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3202, MSC 7808, Bethesda, MD
20892, (301) 996-5819, zhengli@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-11-304: Development of Appropriate Pediatric Formulations
and Drug Delivery Systems.
Date: March 2, 2012.
Time: 8 a.m. to 10 a.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Delfina, 530 Pico Boulevard, Santa Monica, CA
90405.
Contact Person: Dan D Gerendasy, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3218, MSC 7843, Bethesda, MD
20892, (301) 408-9164, gerendad@csr.nih.gov.
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group; Biostatistical Methods and Research Design
Study Section.
Date: March 2, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Kabuki, 1625 Post Street, San Francisco, CA 94115.
Contact Person: Tomas Drgon, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3152, MSC 7770, Bethesda, MD 20892, (301) 435-
1017, tdrgon@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-09-259 and PAR-09-260: Optimization of Small Molecule
Probes for the Nervous System.
Date: March 2, 2012.
Time: 10 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Delfina, 530 Pico Boulevard, Santa Monica, CA
90405.
Contact Person: Dan D Gerendasy, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3218, MSC 7843, Bethesda, MD
20892, (301) 408-9164, gerendad@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: January 27, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-2324 Filed 2-1-12; 8:45 am]
BILLING CODE 4140-01-P
